Company History

In December 2019, Smart Pharma Suzhou invested over￥30 million and established a top notch R&D center in accordance with FDA standards in Taicang Biomedical Industrial Park.

In June 2021, the Company has obtained a license to use a 60-acre land located at 77 Mengxi Road in the Taicang Biomedical Industrial Park. The Company plans to invest over￥3 billion to construct a world-class manufacturing facility which will meet the GMP standards of the United States, the European Union and China. Upon reaching the production capacity, this facility will generate approximately￥1 billion in annual sales and contribute approximately￥200 million in taxes. This project has been nominated as the high priority project by the government of Jiangsu Province.

To date, we have completed the pre-clincial work of over 10 innovative drugs and a number of them have been advanced to the clinical trial stage.